Research & Grants

Funding Opportunities - Type 2 Diabetes in Youth

Innovative Research to Tackle the Epidemic of Youth-Onset
Type 2 Diabetes

ADA Type 2 Diabetes in Youth Research Awards RFA

ADA is soliciting proposals to address key knowledge gaps in youth-onset T2D in order to better understand, prevent, treat, and ultimately induce remission for the rapidly increasing numbers of affected individuals. Applications that focus on disadvantaged lower socioeconomic level families and patients where the burden of disease is greatest are strongly encouraged. Emphasis will be placed on clinical research and translation.   

IMPORTANT TIMELINES

AWARD TYPEOPEN DATESUBMISSION DEADLINE
(5PM ET)		EARLIEST AWARD START DATE
DEVELOPMENT
Junior Faculty

- Letter of Interest (LOI):  October 3, 2023

- Invitation to Apply from ADA: December 20, 2023

- LOI: November 30, 2023

- Application: February 1, 2024

July 1, 2024
RESEARCH
Innovative Clinical or Translational Science

- Letter of Interest (LOI): October 3, 2023

- Invitation to Apply from ADA: December 20, 2023

- LOI: November 30, 2023

- Application: February 1, 2024

July 1, 2024
Innovative Basic Science

- Letter of Interest (LOI): October 3, 2023

- Invitation to Apply from ADA: December 20, 2023

- LOI: November 30, 2023

- Application: February 1, 2024

July 1, 2024

Development Awards

Award Summary

Description: These awards support early investigators as they establish independence as diabetes researchers. Refer to the RFA for further details.

Award Term: Up to 3 years
Applicant: Any level faculty up to & including Assistant Professor or equivalent, ≤10 years research experience beyond terminal degree
Maximum Funding: $138,000/year, plus optional student loan repayment ($10K/year)
Support: Project support & PI salary up to $75K (excluding fringe)
Indirect Support: Up to 10% of directs
Citizenship: Authorized to work in U.S. or U.S. possessions
Deadline: FEBRUARY 1, 2024


Application Materials:

Research Awards

Award Summary

Description: These awards support research with novel and innovative hypotheses, performed in human subjects, or research approaches to accelerate the transition of scientific discoveries into clinical application. Studies supported with these awards must directly involve human subjects, human samples and/or data, and offer considerable promise for advancing the cure, prevention or treatment. Applications proposing high-risk projects with the potential for high-impact results are encouraged, as are studies that may not be sufficiently developed for traditional funding sources. Refer to the RFA for further details.

Award Term: Up to 3 years
Applicant: Any level faculty
Maximum Funding: $200,000/year
Support: Project support and PI salary up to 20% of total costs
Indirect Support: Up to 10% of directs
Citizenship: Authorized to work in U.S. or U.S. possessions
Deadline: FEBRUARY 1, 2024


Application Materials:

Award Summary

Description: These awards support basic research with novel and innovative hypotheses in any area relevant to the etiology or pathophysiology of diabetes and its complications that holds significant promise for advancing the prevention, cure or treatment of diabetes. Applications proposing high-risk projects with the potential for high-impact results are encouraged, as are studies that may not be sufficiently developed for traditional funding sources. Refer to the RFA for further details.

Award Term: Up to 3 years
Faculty Position: Any level faculty
Support: Awards provide up to $115,000 per year for up to three years, including indirect costs. Up to 20% of total costs may be requested for PI salary support.
Indirect Support: Up to 10% of direct costs.
Citizenship: Applicants must be authorized to work in the United States or U.S. possessions.
Deadline: FEBRUARY 1, 2024


Application Materials:

Other Forms

Questions?

Please contact Research Programs staff at grantquestions@diabetes.org.